Document is current

Any future updates will be listed below

726 Enhancing cancer immunotherapy through synthetic biology: a novel heterologous prime-boost strategy

Crossref DOI link: https://doi.org/10.1136/jitc-2024-SITC2024.0726

Published Online: 2024-11-05

Published Print: 2024-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark